Michael Patrick Donovan net worth and biography

Michael Donovan Biography and Net Worth

Mr. Donovan has served as Vice President of Operations for Axogen since September 2015. Prior to this he was the Director of Operations of Axogen, Inc. from November 2011 and of Axogen Corporation from January 2011 to September 2015. From 1988 to 2010, Mike held positions at Zimmer Holdings in manufacturing, continuous improvement, quality assurance and sterilization, including director of manufacturing from 2002 to 2010. Mike has a B.S. in chemical engineering and an MBA from the University of Akron.

What is Michael Patrick Donovan's net worth?: The estimated net worth of Michael Patrick Donovan is at least $247,707.84 as of March 21st, 2024. Mr. Donovan owns 37,992 shares of AxoGen stock worth more than $247,708 as of April 26th. This net worth approximation does not reflect any other assets that Mr. Donovan may own. Additionally, Mr. Donovan receives an annual salary of $406,020.00 as VP at AxoGen. Learn More about Michael Patrick Donovan's net worth.
How old is Michael Patrick Donovan?: Mr. Donovan is currently 59 years old. There are 5 older executives and no younger executives at AxoGen. The oldest executive at AxoGen is Mr. Angelo G. Scopelianos Ph.D., Chief Research & Development Officer, who is 68 years old. Learn More on Michael Patrick Donovan's age.
What is Michael Patrick Donovan's salary?: As the VP of AxoGen, Inc., Mr. Donovan earns $406,020.00 per year. There are 2 executives that earn more than Mr. Donovan. The highest earning executive at AxoGen is Ms. Karen Zaderej, Chairman, President & CEO, who commands a salary of $852,180.00 per year. Learn More on Michael Patrick Donovan's salary.
How do I contact Michael Patrick Donovan?: The corporate mailing address for Mr. Donovan and other AxoGen executives is 13631 PROGRESS BLVD. SUITE 400, ALACHUA FL, 32615. AxoGen can also be reached via phone at (386) 462-6800 and via email at [email protected]. Learn More on Michael Patrick Donovan's contact information.
Has Michael Patrick Donovan been buying or selling shares of AxoGen?: Michael Patrick Donovan has not been actively trading shares of AxoGen within the last three months. Most recently, Michael Patrick Donovan sold 6,033 shares of the business's stock in a transaction on Thursday, March 21st. The shares were sold at an average price of $7.68, for a transaction totalling $46,333.44. Following the completion of the sale, the vice president now directly owns 37,992 shares of the company's stock, valued at $291,778.56. Learn More on Michael Patrick Donovan's trading history.
Who are AxoGen's active insiders?: AxoGen's insider roster includes Michael Donovan (VP), Maria Martinez (Insider), and Karen Zaderej (CEO). Learn More on AxoGen's active insiders.
Are insiders buying or selling shares of AxoGen?: In the last twelve months, AxoGen insiders bought shares 3 times. They purchased a total of 30,000 shares worth more than $188,900.00. In the last twelve months, insiders at the medical equipment provider sold shares 7 times. They sold a total of 165,681 shares worth more than $1,387,449.78. The most recent insider tranaction occured on March, 21st when CEO Karen L Zaderej sold 39,280 shares worth more than $301,670.40. Insiders at AxoGen own 7.2% of the company. Learn More about insider trades at AxoGen.
Information on this page was last updated on 3/21/2024.

Michael Patrick Donovan Insider Trading History at AxoGen

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/21/2024	Sell	6,033	$7.68	$46,333.44	37,992
3/7/2024	Sell	36,310	$8.81	$319,891.10	35,708
7/21/2021	Sell	1,935	$20.04	$38,777.40	40,839
11/9/2020	Sell	17,617	$15.00	$264,255.00	26,029
6/13/2019	Sell	20,000	$20.00	$400,000.00	18,974

Michael Patrick Donovan Buying and Selling Activity at AxoGen

AxoGen Company Overview

AxoGen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen, Inc. is headquartered in Alachua, Florida.

Today's Range

Now: $6.52

$6.46

$6.87

50 Day Range

MA: $8.43

$6.50

$10.69

2 Week Range

Now: $6.52

$3.45

$10.83

Volume

232,904 shs

Average Volume

407,729 shs

Market Capitalization

$284.86 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.03

The "Smart Money" Is Ready for May 1st Are You?

From Stansberry Research | Ad

Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company.

One Former Wall St. Trader Explains Why…

Michael Donovan Biography and Net Worth

What is Michael Patrick Donovan's net worth?

How old is Michael Patrick Donovan?

What is Michael Patrick Donovan's salary?

How do I contact Michael Patrick Donovan?

Has Michael Patrick Donovan been buying or selling shares of AxoGen?

Who are AxoGen's active insiders?

Are insiders buying or selling shares of AxoGen?